Skip to the page

Data / Form D filings / TVAX Biomedical LLC

TVAX Biomedical LLC: Form D filings

TVAX Biomedical LLC, a biotechnology company in Lenexa, KS, filed 5 Form D notices with the SEC between 2010 and 2011. The latest, on April 29, 2011, reports $3.5 million sold of a $11.2 million offering to 87 investors.

Find out what TVAX Biomedical LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
8006 REEDER STREET, Lenexa, KS, 66214
Phone
(913) 492-2221
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Missouri
Revenue range
No Revenues
Exemptions claimed
Rule 506
SEC identifier (CIK)
1358793

The full lists. Form D filings in Kansas: 193 rows, $9.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get this list free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 29, 2011Amendment$11,200,000$3,487,741$7,712,25987Apr 2, 2010sec.gov
Aug 6, 2010Amendment$2,600,000$2,000,391$599,6091Jan 15, 2010sec.gov
Aug 6, 2010Amendment$11,200,000$691,826$10,508,17421Apr 2, 2010sec.gov
Jun 30, 2010New notice$11,200,000$606,189$10,593,81115Apr 2, 2010sec.gov
Feb 12, 2010New notice$2,600,000$1,700,386$899,6141Jan 15, 2010sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Timothy E. WurstExecutive Officer, Director
Catherine E. LucaseyDirector
Gary W. WoodExecutive Officer, Director
Rex E. WigginsExecutive Officer, Director

Every Form D from the week of Apr 25, 2011 · All recent filings in Kansas · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what TVAX Biomedical LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.